Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

@article{Murray2001OpenlabelRT,
  title={Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.},
  author={M. Murray and M. Deer and J. Ferguson and P. Dexter and S. Bennett and S. Perkins and F. Smith and K. Lane and L. Adams and W. Tierney and D. Brater},
  journal={The American journal of medicine},
  year={2001},
  volume={111 7},
  pages={
          513-20
        }
}
PURPOSE Because the bioavailability of oral furosemide is erratic and often incomplete, we tested the hypothesis that patients with heart failure who were treated with torsemide, a predictably absorbed diuretic, would have more favorable clinical outcomes than would those treated with furosemide. PATIENTS AND METHODS We conducted an open-label trial of 234 patients with chronic heart failure (mean [+/- SD] age, 64 +/- 11 years) from an urban public health care system. Patients received oral… Expand
Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis.
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
Characterization of the precipitants of hospitalization for heart failure decompensation.
  • S. Bennett, G. Huster, +4 authors M. Pressler
  • Medicine
  • American journal of critical care : an official publication, American Association of Critical-Care Nurses
  • 1998
Hormones and hemodynamics in heart failure.
...
1
2
3
...